Coronavirus Pandemic

About Us

Welcome 

The Division of Pediatric Endocrinology is actively engaged in clinical care, research, teaching and community service in the areas of endocrinology and diabetes. The Division has continued to expand its clinical and research activities to meet the ongoing health needs of the San Diego pediatric community.

Our Division provides care for over 10,000 patients each year. We pride ourselves on providing a high caliber of endocrine and diabetes treatment to our patients and their families.

Rady Children's Hospital San Diego is a destination for pediatric care in California. As the largest children's hospital in the state and the sixth largest in the United States, it is nationally recognized for medical excellence, with rankings in all ten pediatric specialties by U.S. News & World Report. Our expert physicians, representing over 50 medical and surgical specialties, serve 91 percent of the region's children. Further, as a university affiliated health system, Rady Children's encompasses the clinical, teaching, research, and public service of the prestigious University of California San Diego campus. 

Innovative Research and Clinical Care

Our investigators within the Pediatric Diabetes Research Center (PDRC) perform pioneering research into regenerative and stem cell-based therapies for type 1 diabetes, cutting-edge computational and molecular genetic techniques for assessing diabetes disease risk, biomarker development and investigations of causes of cell death in those with diabetes, and links between maternal metabolism and obesity and diabetes in their children.

Our clinical program provides treatment for both common and uncommon endocrine conditions, including care for those who would benefit from complex multidisciplinary evaluation and treatment. We operate several multidisciplinary clinics, including those dedicated to Turner's syndrome, transgender health, and differences in sex development. Regionally, we host a multidisciplinary conference to care for children with thyroid cancer, and nationally, we participate in a collaborative effort for the type 1 diabetes quality improvement in partnership with an organization committed to improving diabetes patient outcomes by reducing barriers and increasing access to technology.